Brief: Pieris Pharmaceuticals Inc Says QTRLY Loss Per Share $0.24
Nov 2 (Reuters) - Pieris Pharmaceuticals Inc PIRS.O :
* PIERIS PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.24
* PIERIS PHARMACEUTICALS INC - QTRLY REVENUE $4.1 MILLION
VERSUS
$2.9 MILLION
Source text for Eikon: [https://bit.ly/2ZUmaN3]
Further company coverage: PIRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Palvella Therapeutics
See all newsPalvella Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Palvella Therapeutics Q2 net loss widens on higher expenses
Brief: Palvella Therapeutics Announces New Data From The Phase 2 Toiva Trial Of Qtorin™ Rapamycin In Cutaneous Venous Malformations
Brief: Palvella Therapeutics Announces Uplisting To The Nasdaq Global Market
Palvella Therapeutics' Q1 net loss widens on higher costs